Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
CBC
Support for Students with Disabilities
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
Program Resources
You are here
Home
>
The New England journal of medicine
The New England journal of medicine
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Mutations in DSTYK and dominant urinary tract malformations.
Mutations in DSTYK and dominant urinary tract malformations.
Can age-associated memory decline be treated?
Can age-associated memory decline be treated?
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »
